Corporate Development Services
Extera focuses on providing superior corporate development services to life science companies. We specialize in planning and executing strategic transactions with industry partners and financial investors across the globe. Extera takes a pragmatic and aggressive approach to corporate development and is committed to closing high value transactions for our clients. Since its inception in 2007, Extera has supported a range of clients from early start-ups to global life science companies.
The firm works diligently and persistently until our clients’ strategic objectives are met. Extera’s negotiation skills, access to decision makers, global presence and commitment are responsible for its reputation as a premier life science corporate development advisory firm. Our areas of focus include biotechnology, specialty pharmaceuticals, generics, medical technology, diagnostics and clinical imaging. Extera operates out of offices in the US, Europe, Japan and Israel.
Our
Team
Extera’s team has been working together for over a decade. Our team’s collective experience exceeds one hundred and fifty years of corporate development and management experience in the biotechnology and medical device sectors.
Track Record
Extera has facilitated a broad range of strategic transactions including mergers, structured acquisitions, research and development collaborations, technology and product licensing, global distribution transactions and financial investments by venture capital and private equity firms.
Private Placement
Undisclosed
Acquisition
$83,000,000
Collaboration
$500,000,000
Collaboration
$350,000,000
Private Placement
Undisclosed
Private Placement
Undisclosed
Acquisition
Undisclosed
Acquisition
$93,000,000
Collaboration
Undisclosed
Licensing
$75,000,000
Private Placement
$28,000,000
Licensing
$8,000,000
Collaboration
Undisclosed
Collaboration
Undisclosed
Collaboration
Undisclosed
Acquisition
$300,000,000
Acquisition
$250,000,000
Funding & Distribution
$5,000,000
Collaboration
Undisclosed
Private Placement
$8,000,000
Distribution
Undisclosed
Distribution
Undisclosed
Private Placement
$21,000,000
Private Placement
Undisclosed
Licensing
$95,000,000
Reverse Take Over
$65,000,000
Case studies
Extera’s extensive analysis and planning, aggressive execution, dedication and commitment even under challenging situations are responsible for the high rate of success in closing transactions.
Asset Sales
$200,000,000
Acquisition
$130,000,000
Licensing
$58,000,000
Research Collaboration
$300,000,000
Acquisition
$59,000,000
Private Placement
$12,000,000
Equity Investment
Undisclosed
Equity Investment
Undisclosed
Venture Creation
Extera leverages broad market reach and operational expertise to create and accelerate new biotechnology and medical device ventures that seek to improve clinical outcomes, enhance quality of life and reduce healthcare costs.
News
Contact
Us
Extera Partners Headquarters:
65 William Street
Suite #200
Wellesley, MA 02481 USA
Tel: +1 (781) 591-8927
Please call us or contact Extera via e-mail with any inquiry
© Extera Partners, 2017